Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
Sogol Javaheri, MD, MPH
Editorial Advisory Board Member, Harvard Health Publishing
Dr. Sogol Javaheri is an assistant professor at Harvard Medical School and a physician in the division of sleep and circadian rhythm disorders at Brigham and Women's Hospital in Boston. She graduated from Case Western Reserve University with her MD as well as a masters in bioethics. She completed an internal medicine residency and a sleep fellowship at Brigham and Women's, and subsequently obtained her MPH at the Harvard T.H. Chan School of Public Health.
In addition to seeing patients, she serves as the director of the Atrial Fibrillation Center of Excellence Sleep Clinic, and as associate program director for the MGB Clinical Sleep Fellowship program. Her primary research focus is sleep disorders and cardiovascular disease, and she is currently leading a clinical trial among patients with obstructive sleep apnea and atrial fibrillation.
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
